List of Excipients in API lamivudine and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lamivudine and tenofovir disoproxil fumarate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Mylan Specialty LP | CIMDUO | lamivudine and tenofovir disoproxil fumarate | 49502-450 | CELLULOSE, MICROCRYSTALLINE | |
Mylan Specialty LP | CIMDUO | lamivudine and tenofovir disoproxil fumarate | 49502-450 | CROSCARMELLOSE SODIUM | |
Mylan Specialty LP | CIMDUO | lamivudine and tenofovir disoproxil fumarate | 49502-450 | LACTOSE MONOHYDRATE | |
Mylan Specialty LP | CIMDUO | lamivudine and tenofovir disoproxil fumarate | 49502-450 | MAGNESIUM STEARATE | |
Mylan Specialty LP | CIMDUO | lamivudine and tenofovir disoproxil fumarate | 49502-450 | POLYETHYLENE GLYCOL | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lamivudine and tenofovir disoproxil fumarate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lamivudine and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
lamivudine and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
lamivudine and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
lamivudine and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lamivudine and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
lamivudine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lamivudine and tenofovir disoproxil fumarate drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
lamivudine and tenofovir disoproxil fumarate drug variants containing POWDERED CELLULOSE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing POWDERED CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
lamivudine and tenofovir disoproxil fumarate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
lamivudine and tenofovir disoproxil fumarate drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lamivudine and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Specialty LP | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
>Company | >Ingredient | >NDC |
lamivudine and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.